| 001 |
Elisa Al-hakim |
FORMATIVE RESEARCH WITH IMPACTED POPULATIONS TO INFORM HCV PROGRAM FOR PEOPLE WHO INJECT DRUGS (PWID) |
Epidemiology and Public Health Research |
Abstract |
| 002 |
Afia Amoako |
KNOWLEDGE SYNTHESIS OF PATIENT AND PROVIDER PERCEIVED BARRIERS AND FACILITATORS TO HEPATITIS C (HCV) TREATMENT AMONG HUMAN IMMUNODEFICIENCY VIRUS (HIV) COINFECTED POPULATIONS IN CANADA |
Epidemiology and Public Health Research |
Abstract |
| 003 |
Megan Bardsley |
HEPATITIS C TESTING AND ACCESS TO CARE AMONG PEOPLE WHO INJECT PSYCHOACTIVE DRUGS IN ENGLAND, WALES AND NORTHERN IRELAND: INSIGHTS FROM 2017 NATIONAL SURVEY DATA. |
Epidemiology and Public Health Research |
Abstract |
| 004 |
Megan Bardsley |
THE ASSOCIATION BETWEEN HOMELESSNESS AND HEPATITIS C EXPOSURE AMONG 11,101 PEOPLE WHO INJECT DRUGS IN ENGLAND, WALES AND NORTHERN IRELAND: A CROSS-SECTIONAL STUDY |
Epidemiology and Public Health Research |
Abstract |
| 005 |
Tyler Bartholomew |
BASELINE PREVALENCE AND PREDICTORS OF HIV/HCV INFECTION AMONG PERSONS WHO INJECT DRUGS ACCESSING A SYRINGE SERVICES PROGRAM; MIAMI, FL |
Epidemiology and Public Health Research |
Abstract |
| 006 |
Tyler Bartholomew |
INJECTION DRUG USE, INJECTION RISK AND HIV/HCV STATUS AMONG PEOPLE ACCESSING A SYRINGE SERVICE PROGRAM; A LATENT CLASS ANALYSIS |
Epidemiology and Public Health Research |
Abstract |
| 007 |
Sofia Bartlett |
INCONSISTENCIES IN METHODOLOGY, REPORTING, AND SUBJECTIVE DESCRIPTION OF HEPATITIS C VIRUS REINFECTION RATES AMONG PEOPLE WHO INJECT DRUGS: POTENTIAL CONTRIBUTION TO STIGMA AND DISCRIMINATION? |
Epidemiology and Public Health Research |
Abstract |
| 008 |
Katie Burk |
BARRIERS AND FACILITATORS TO HEPATITIS C TREATMENT USING DIRECTOR ACTING ANTIVIRALS AMONG PEOPLE WHO INJECT DRUGS IN SAN FRANCISCO, CALIFORNIA |
Epidemiology and Public Health Research |
Abstract |
| 009 |
Maia Butsashvili |
BARRIERS OF LINKAGE TO HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS IN GEORGIA |
Epidemiology and Public Health Research |
Abstract |
| 010 |
Athina Chounta |
STUDY OF COMPLIANCE IN IV DRUG USERS WITH HEPATITIS C. 10 YEARS FOLLOW UP DATA FROM A UNIVERSITY HOSPITAL IN GREECE. |
Epidemiology and Public Health Research |
Abstract |
| 011 |
Karli Hochstatter |
DETECTING HEPATITIS C VIRUS TRANSMISSION CLUSTERS USING REMNANT SERUM SPECIMENS FROM KEY AFFECTED POPULATIONS TESTED IN PUBLIC HEALTH SETTINGS |
Epidemiology and Public Health Research |
Abstract |
| 012 |
Zahid Butt |
GEOGRAPHIC CASCADE OF HCV CARE: A TOOL FOR TARGETED INTERVENTIONS AND PROGRAM EVALUATION |
Epidemiology and Public Health Research |
Abstract |
| 013 |
Beth Catlett |
EVALUATION OF HCV RNA TESTING FROM FINGER-STICK CAPILLARY DRIED BLOOD SPOT AND VENEPUNTURE-COLLECTED SAMPLES: A COHORT STUDY |
Epidemiology and Public Health Research |
Abstract |
| 014 |
Lara Marquez |
WHAT IS THE OPTIMAL HCV ELIMINATION STRATEGY AMONG PWID IN A MIDDLE-INCOME, HIGH BURDEN SETTING? A MODELING AND ECONOMIC ANALYSIS IN TIJUANA, MEXICO |
Epidemiology and Public Health Research |
Abstract |
| 015 |
Bridget Draper |
COMMUNITY-BASED POINT-OF-CARE TESTING AND TREATMENT FOR PEOPLE WHO INJECT DRUGS IN MYANMAR |
Epidemiology and Public Health Research |
Abstract |
| 016 |
Peter Collin |
CHRONIC MEDICAL DISEASES AND HEALTHCARE UTILIZATION IN PEOPLE WHO CURRENTLY INJECT DRUGS (PCID) WITH HEPATITIS C (HCV) IN NEW YORK CITY |
Epidemiology and Public Health Research |
Abstract |
| 017 |
Jeffrey Craig |
UTILIZATION OF POINT OF CARE HEPATITIS C TESTING ON PRIORITY POPULATIONS IN AN OUTREACH SETTING |
Epidemiology and Public Health Research |
Abstract |
| 018 |
Olanrewaju Onigbogi |
WILLINGNESS TO ACCESS COMMUNITY-BASED HEPATITIS C AND HIV TESTING CENTRES AMONG INJECTING DRUG USERS IN LAGOS NIGERIA |
Epidemiology and Public Health Research |
Abstract |
| 019 |
Joseph Doyle |
HEPATITIS B IMMUNITY AND SUSCEPTABILITY AMONG PEOPLE LIVING WITH HIV AND HEPATITIS C CO-INFECTION IN MELBOURNE, AUSTRALIA |
Epidemiology and Public Health Research |
Abstract |
| 020 |
Joseph Doyle |
RISK BEHAVIOURS FOLLOWING HEPATITIS C TREATMENT AMONG GAY AND BISEXUAL MEN LIVING WITH HIV IN MELBOURNE, AUSTRALIA |
Epidemiology and Public Health Research |
Abstract |
| 021 |
Elizabeth Crock |
TOWARDS OPTIMISING CARE AND PREVENTION FOR PEOPLE WHO INJECT DRUGS, AND LIVING WITH HIV AND VIRAL HEPATITIS IN MELBOURNE, AUSTRALIA - EVALUATION OF AN INTEGRATED HIV AND HOMELESSNESS NURSING SERVICE |
Epidemiology and Public Health Research |
Abstract |
| 022 |
Rimunchung Duroi Chongdur |
A NETWORK OF PEOPLE WHO INJECT DRUGS SUCCESSFULLY PRODUCED A STATE WIDE AUTHENTICATED HCV PREVALENCE DATA AMONG PWIDS AND THEIR SPOUSES. PERHAPS, STILL THE ONLY STATE DATA EVER PRODUCED. |
Epidemiology and Public Health Research |
Abstract |
| 023 |
Ragnheidur Fridriksdottir |
RE-ENGAGEMENT IN CARE FOR HEPATITIS C IN THE TRAP HEPC PROGRAM: EVERY PATIENT DESERVES A SECOND CHANCE. |
Epidemiology and Public Health Research |
Abstract |
| 024 |
Ed Hall |
HEPATITIS C SCREENING AND TREATMENT WITHIN AN OPIOID TREATMENT PROGRAM: CURRENT CHALLENGES AND POTENTIAL SOLUTIONS |
Epidemiology and Public Health Research |
Abstract |
| 025 |
Paul Harkin |
INTEGRATED HARM REDUCTION PROGRAMMING: SYRINGE SERVICE PROGRAMS AND HIV/HCV TESTING |
Epidemiology and Public Health Research |
Abstract |
| 026 |
Emmanuelle Huchet |
DISPARITY AMONG MARGINALIZED PATIENTS IN THE HEPATITIS C CASCADE OF CARE IN A SPECIALIZED CLINIC? |
Epidemiology and Public Health Research |
Abstract |
| 027 |
Brendan Jacka |
SHORT-TERM ‘CHEQUE EFFECTS’ ON DRUG CONSUMPTION BEHAVIOUR AND THEIR ASSOCIATION WITH DETERMINANTS OF HCV RISK AMONG PEOPLE WHO INJECT DRUGS |
Epidemiology and Public Health Research |
Abstract |
| 028 |
Naveed Janjua |
ASSOCIATION BETWEEN PRESCRIPTION OPIOIDS AND HEPATITIS C VIRUS SEROCONVERSION AMONG PEOPLE WHO USE INJECTION DRUGS IN BRITISH COLUMBIA |
Epidemiology and Public Health Research |
Abstract |
| 029 |
Amy Jessop |
PILOT TESTING “TAKE CHARGE, GET CURED” WITH METHADONE PATIENTS: A MHEALTH TOOL ADDRESSING HCV TREATMENT INITIATION |
Epidemiology and Public Health Research |
Abstract |
| 030 |
Mohammed Abul Kalam |
RISKY BEHAVIOR AND HIV/HCV KNOWLEDGE OF WOMEN COMMERCIAL SEX WORKERS (WCSWs) AND INJECTING DRUG USERS (IDUs) IN RAJSHAHI CITY OF BANGLADESH |
Epidemiology and Public Health Research |
Abstract |
| 031 |
Shashi Kapadia |
INCREASING NUMBER OF PROVIDERS TREATING HEPATITIS C AFTER DIRECT ACTING ANTIVIRALS IN THE UNITED STATES: IMPLICATIONS FOR TREATMENT ACCESS. |
Epidemiology and Public Health Research |
Abstract |
| 032 |
Andreas Kapatais |
HIV-PERCENTAGE OF ALL TYPES OF HEPATITIS VIRUS IN IVDU USERS AMONG THE POPULATION OF HELLAS |
Epidemiology and Public Health Research |
Abstract |
| 033 |
Andreas Kapatais |
CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF CHC ACCESS TO TREATMENT WITH DAAs |
Epidemiology and Public Health Research |
Abstract |
| 034 |
Jacob Ziff |
PREDICTORS OF HEPATITIS C VIRUS TREATMENT OUTCOMES IN A HARM REDUCTION-FOCUSED PRIMARY CARE PROGRAM IN NEW YORK CITY |
Clinical Research |
Abstract |
| 035 |
Imtiaz Alam |
IMPROVING PWID HEPATITIS C CARE CASCADE THROUGH ELECTRONIC HEALTH ENGAGEMENT |
Clinical Research |
Abstract |
| 036 |
Olga Anagnostou |
EXTENDING THE CRITERIA FOR CHRONIC HEPATITIS C (CHC) TREATMENT WITH DIRECT ACTING ANTIVIRALS (DAAS) IN GREECE: BEST BENEFIT IN LINKAGE TO CARE FOR PATIENTS WHO INJECT DRUGS (PWID’S) |
Clinical Research |
Abstract |
| 037 |
Olga Anagnostou |
HCV MICRO ELIMINATION IN A REAL WORLD SETTING AT SUBSTITUTION PROGRAMS IN ATHENS, GREECE |
Clinical Research |
Abstract |
| 038 |
Yesenia Aponte-Melendez |
HEALTH CARE RELATED STIGMA AMONG PEOPLE WHO INJECT DRUGS IN NEW YORK CITY |
Clinical Research |
Abstract |
| 039 |
Danielle Back |
BARRIERS TO HEPATITIS C TREATMENT PERSIST FROM THE INTERFERON-ERA |
Clinical Research |
Abstract |
| 040 |
Sahar Bajis |
HEPATITIS C VIRUS TESTING, LIVER DISEASE ASSESSMENT AND TREATMENT UPTAKE AMONG PEOPLE WHO INJECT DRUGS PRE- AND POST-UNIVERSAL ACCESS TO DIRECT-ACTING ANTIVIRAL TREATMENT IN AUSTRALIA: THE LIVERLIFE STUDY |
Clinical Research |
Abstract |
| 041 |
Lewis Beer |
SVR12 OUTCOMES IN CHRONIC HCV INFECTED PWID WHO ARE NON-COMPLIANT WITH RECOMMENDED TREATMENT REGIMENS |
Clinical Research |
Abstract |
| 042 |
Lewis Beer |
DOES INJECTING BEHAVIOUR CHANGE FOLLOWING DIRECT ACTING ANTIVIRAL HEPATITIS C THERAPY IN PERSONS WHO INJECT DRUGS ? |
Clinical Research |
Abstract |
| 043 |
Jasna Cernosa |
SUSTAINED VIROLOGICAL RESPONSE TO HCV TREATMENT WITH DIRECT-ACTING ANTIVIRALS IN PEOPLE WHO INJECT DRUGS (PWID) AND NON-PWID: RESULTS OF A NATIONAL COMPARATIVE SURVEY IN SLOVENIA |
Clinical Research |
Abstract |
| 044 |
Brian Conway |
CHARACTERIZATION OF PATIENTS IN CANADA WITH CHRONIC HCV INFECTION INITIATING DAA THERAPY BASED ON RISK FOR HCV TRANSMISSION AND RESPONSE TO TREATMENT: THE REAL-WORLD C-RESPECT STUDY |
Clinical Research |
Abstract |
| 045 |
Brian Conway |
REAL-WORLD EFFICACY OF SALVAGE THERAPIES FOR THE TREATMENT OF CHRONIC HEPATITIS C VIRUS INFECTION IN TREATMENT EXPERIENCED PEOPLE WHO INJECT DRUGS (PWID) |
Clinical Research |
Abstract |
| 046 |
Jason Edwards |
IDENTIFICATION OF HCV AND LINKAGE TO CARE FROM A DETOXIFICATION UNIT – A NOVEL STRATEGY FOR HCV MICRO-ELIMINATION 431 |
Clinical Research |
Abstract |
| 047 |
Scott Fenwick |
SPONTANEOUS CLEARANCE OF HEPATITIS C VIRUS IN A COHORT OF PATIENTS ENROLLED IN A HARM REDUCTION CLINIC IN NEW BRUNSWICK, CANADA: 2014-2018 |
Clinical Research |
Abstract |
| 048 |
Urmo Jaanimägi |
INFLUENCE OF SOCIAL DETERMINANTS OF HEALTH AND SUBSTANCE USE CHARACTERISTICS ON PERSONS WHO USE DRUGS PURSUIT OF CARE FOR HEPATITIS C VIRUS INFECTION |
Clinical Research |
Abstract |
| 049 |
Robin Jindal |
HCV TREATMENT ADHERENCE AMONG PEOPLE WHO INJECT DRUGS (PWID) |
Clinical Research |
Abstract |
| 050 |
Martin Kåberg |
REAL-WORLD TREATMENT DATA FROM A NEEDLE EXCHANGE WITH A HIGH PREVALENCE OF HCV AND AMPHETAMINE USE |
Clinical Research |
Abstract |
| 051 |
Shashi Kapadia |
HCV SEEK, TEST, AND RAPID-TREATMENT (HCV-ST&RT) FOR YOUNG PEOPLE WHO INJECT DRUGS WITH HEPATITIS C– DESCRIPTION OF MODEL AND BASELINE CHARACTERISTICS. |
Clinical Research |
Abstract |
| 052 |
Tianna Magel |
HCV AMONG CIRRHOTIC PEOPLE WHO USE/INJECT DRUGS (PWID): RESPONSE TO THERAPY AND LONG-TERM FOLLOW-UP |
Clinical Research |
Abstract |
| 053 |
Tianna Magel |
MULTIDISCIPLINARY CARE AND THE FOUR-LEGGED CHAIR: THE ADDICTION LEG |
Clinical Research |
Abstract |
| 054 |
Tianna Magel |
MORBIDITY AND MORTALITY IN HCV-INFECTED PEOPLE WHO USE DRUGS (PWUD): BEYOND THE SVR12 |
Clinical Research |
Abstract |
| 055 |
Valérie Martel-laferrière |
EFFECT OF A SINGLE-DAY INVESTIGATION FOR HCV INFECTION ON TREATMENT INITIATION AMONG PWID, BEFORE AND AFTER UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS |
Clinical Research |
Abstract |
| 056 |
Sarah Kattakuzhy |
HCV REINFECTION NOT ASSOCIATED WITH OAT ENGAGEMENT, DRUG USE, OR SEXUAL RISK IN PERSONS WITH OPIOID USE DISORDER AND INJECTION DRUG USE: DATA FROM THE ANCHOR STUDY |
Clinical Research |
Abstract |
| 057 |
Kate Mason |
FEASIBILITY OF RAPID HEPATITIS C POINT-OF-CARE RNA TESTING AND TREATMENT AT AN INTEGRATED SUPERVISED CONSUMPTION SITE IN TORONTO, CANADA |
Clinical Research |
Abstract |
| 058 |
Christian Sharkey |
WORKING TOWARDS MICRO-ELIMINATION OF HCV IN PWID. A DIRECT OBSERVED THERAPY VS FORTNIGHTLY COLLECTION STUDY FOR HCV TREATMENT – ADVANCE HCV STUDY |
Clinical Research |
Abstract |
| 059 |
Jeffrey Weiss |
RANDOMIZED CLINICAL TRIAL TO TEST E-HEALTH INTERVENTIONS TO IMPROVE ADHERENCE TO A ONCE-DAILY SINGLE-TABLET REGIMEN IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION |
Clinical Research |
Abstract |
| 060 |
Vincenzo Messina |
AN INNOVATIVE MODEL FOR LINKAGE TO CARE OF PWID WITH HCV INFECTION IN ITALY |
Clinical Research |
Abstract |
| 061 |
Brianna Norton |
DRUG USER HEALTHCARE DELIVERED ONSITE AT A SYRINGE EXCHANGE: HCV, MAT, AND PREP |
Clinical Research |
Abstract |
| 062 |
Anne Øvrehus |
RISK BEHAVIOURS AND PREVALENCE OF BLOOD BORNE INFECTIONS IN YOUNG PEOPLE SEEKING TREATMENT OR ADVICE FOR DRUG USE – THE POTENTIAL OF DRIED BLOOD SPOTS. |
Clinical Research |
Abstract |
| 063 |
Anne Øvrehus |
PATIENT REPORTED EXPERIENCE AND OUTCOME OF HEPATITIS C TREATMENT IN PEOPLE WHO INJECT DRUGS OR RECEIVING OPIATE SUBSTITUTION THERAPY. A PEER INITIATED SURVEY IN DENMARK. |
Clinical Research |
Abstract |
| 064 |
Irene Pericot-Valverde |
PATTERNS AND CORRELATES OF CIGARETTE SMOKING AMONG PEOPLE WHO INJECT DRUGS RECEIVING TREATMENT FOR HEPATITIS C |
Clinical Research |
Abstract |
| 065 |
Phillip Read |
THE CHALLENGE OF FOLLOW-UP: HEPATOCELLULAR CARCINOMA SURVEILLANCE IN MARGINALIZED PATIENTS WITH CIRRHOSIS TREATED FOR HCV IN A LOW THRESHOLD PRIMARY HEALTH CARE SETTING |
Clinical Research |
Abstract |
| 066 |
Emma Robinson |
EVALUATING TREATMENT AS PREVENTION AMONG PEOPLE WHO INJECT DRUGS IN DUNDEE FOR HCV (ERAPID-HCV) |
Clinical Research |
Abstract |
| 067 |
Elana Rosenthal |
HIGH UPTAKE OF COLLOCATED OPIOID AGONIST THERAPY WITH DAA IS ASSOCIATED WITH REDUCED RISKS AND IMPROVED SVR IN PEOPLE WITH ACTIVE INJECTION DRUG USE: DATA FROM THE ANCHOR STUDY |
Clinical Research |
Abstract |
| 068 |
Raphael Schubert |
INTERIM RESULTS OF AN ONGOING PROJECT TO ELIMINATE CHRONIC HEPATITIS C IN PWID WITH ONGOING INTRAVENOUS DRUG USE AND A HIGH RISK OF NON-ADHERENCE TO DIRECT-ACTING ANTIVIRALS IN VIENNA |
Clinical Research |
Abstract |
| 069 |
Raphael Schubert |
INTERIM RESULTS OF AN AUSTRIAN HCV-MICROELIMINATION PROJECT TO INCREASE SCREENING AND LINKAGE TO CARE IN PWID IN VIENNA |
Clinical Research |
Abstract |
| 070 |
Andrew Seaman |
A NOVEL HEPATITIS C MICRO-ELIMINATION MODEL IN A LARGE HEALTHCARE FOR THE HOMELESS ORGANIZATION |
Clinical Research |
Abstract |
| 071 |
Omar Sims |
TIME TO TREATMENT DISFAVORS HCV PATIENTS WITH HIV CO-INFECTION |
Clinical Research |
Abstract |
| 072 |
Omar Sims |
PREVALENCE OF ALCOHOL AND SUBSTANCE USE IN HIV/HCV CO-INFECTED PATIENTS RECEIVING ANTIRETROVIRALS |
Clinical Research |
Abstract |
| 073 |
Jan Tait |
THE ROAD TO HEPATITIS C VIRUS (HCV) ELIMINATION: RE-INFECTIONS AFTER SUSTAINED VIRAL RESPONSE (SVR), WHY WE MUST RETEST AND OFFER RETREATMENT |
Clinical Research |
Abstract |
| 074 |
Clara Thierfelder |
VERY LATE RELAPSE OF CHRONIC HEPATITIS C TREATED WITH LDV/SOF |
Clinical Research |
Abstract |
| 075 |
Gunnar Thingnes |
CHALLENGES IN DELIVERY OF POINT OF CARE TESTING FOR HCV RNA IN A MOBILE HEALTH SERVICE FOR PEOPLE WHO INJECT DRUGS (PWID) |
Clinical Research |
Abstract |
| 076 |
Effrosyni Tsirogianni |
HCV MICROELIMINATION ΕNHANCED BY A NETWORK CONNECTING ALL DETOXIFICATION AND SUBSTITUTION PROGRAMS WITH AN EXPERTIZED HEPATOLOGY CLINIC IN NORTHERN GREECE |
Clinical Research |
Abstract |
| 077 |
Jorge Valencia |
RECENT ABSTINENCE AT THE MOMENT TO INITIATE HCV TREATMENT IS NO GUARANTEE TO AVOID HCV REINFECTIONS |
Clinical Research |
Abstract |
| 078 |
Tatiana Vera |
FACTORS CONTRIBUTING TO HCV TREATMENT FAILURE AND SUCCESSFUL RETREATMENT IN PEOPLE WHO USE DRUGS |
Clinical Research |
Abstract |
| 079 |
Shaokun Liu |
FACTORS ASSOCIATED WITH THE IMPROVEMENT OF FAMILY RELATIONSHIPS AMONG METHADONE MAINTENANCE TREATMENT CLIENTS: A LONGITUDINAL ANALYSIS OF REGISTER DATA FROM 15 CLINICS IN GUANGDONG, CHINA |
Epidemiology and Public Health Research |
Abstract |
| 080 |
Marina Kornilova |
FACTORS ASSOCIATED WITH OVERDOSE AMONG PEOPLE WHO INJECT DRUGS IN UKRAINE |
Epidemiology and Public Health Research |
Abstract |
| 081 |
Marina Kornilova |
THE SEXUAL PARTNERS OF PEOPLE WHO INJECT DRUGS IN UKRAINE IS THE NEXT TARGET OF THE HIV EPIDEMIC IF NO PREVENTION APPLIED |
Epidemiology and Public Health Research |
Abstract |
| 082 |
Cheap FohLow |
MOST AT RISK POPULATIONS AND HEALTHCARE WORKERS PERSPECTIVES ON EXISTING SERVICES FOR HEPATITIS C CARE AND SUPPORT IN MALAYSIA |
Epidemiology and Public Health Research |
Abstract |
| 083 |
Qian Lu |
DEFINING DOSING-RELATED TAPERING CHARACTERISTICS TO DECREASE CONCURRENT HEROIN USE: A RETROSPECTIVE COHORT STUDY OF METHADONE MAINTENANCE TREATMENT PARTICIPANTS IN GUANGDONG, CHINA |
Epidemiology and Public Health Research |
Abstract |
| 084 |
Amy Malaguti |
PSYCHOSOCIAL PREDICTORS OF RISK OF HEPATITIS C (HCV) REINFECTION IN PEOPLE WHO INJECT DRUGS ON HCV TREATMENT. |
Epidemiology and Public Health Research |
Abstract |
| 085 |
Francesco Manca |
NOVEL HCV SCREENING STRATEGIES FOR HARD TO REACH POPULATIONS: ARE THEY COST-EFFECTIVE? |
Epidemiology and Public Health Research |
Abstract |
| 086 |
Madeleine Caven |
HCV DIAGNOSIS AND TREATMENT, IMPACT OF KNOWLEDGE OF HCV STATUS ON BEHAVIOUR OF PEOPLE WHO INJECT DRUGS, A SERVICE EVALUATION, THE HOOKED C PROJECT |
Epidemiology and Public Health Research |
Abstract |
| 087 |
Natasha Martin |
COST-EFFECTIVENESS OF UNIVERSAL HEPATITIS C VIRUS SCREENING OF PREGNANT WOMEN IN THE UNITED STATES |
Epidemiology and Public Health Research |
Abstract |
| 088 |
Stefanie Materniak |
FINDING THE STARTING POINT TOWARD HEPATITIS C ELIMINATION: IDENTIFYING KNOWN PREVALENT HEPATITIS C CASES IN SOUTHERN NEW BRUNSWICK, CANADA |
Epidemiology and Public Health Research |
Abstract |
| 089 |
Catharina Matheï |
HEPATITIS C RELATED MORTALITY IN A COHORT OF DRUG USERS IN FLANDERS |
Epidemiology and Public Health Research |
Abstract |
| 090 |
April Mazzuca |
THE CEDAR HCV BLANKET PROGRAM: BARRIERS AND FACILITATORS OF HEPATITIS C TREATMENT UPTAKE AMONG INDIGENOUS PEOPLE WHO USE DRUGS IN BC, CANADA. |
Epidemiology and Public Health Research |
Abstract |
| 091 |
Miranda Moore |
USING HEPATITIS C SURVEILLANCE DATA TO PROFILE HEPATITIS C CARE AT SUBSTANCE USE TREATMENT FACILITIES, NEW YORK CITY, 2017–2018 |
Epidemiology and Public Health Research |
Abstract |
| 092 |
Alberto Moriggia |
AGEING WITH ADDICTION: DESCRIBING HEALTH CONDITIONS OF YOUNGER AND OLDER DRUG USERS IN SWITZERLAND |
Epidemiology and Public Health Research |
Abstract |
| 093 |
Margaret O'sullivan |
PROJECT ITTREAT (INTEGRATED COMMUNITY BASED TEST – STAGE-TREAT HCV SERVICE) FOR PEOPLE WHO INJECT DRUGS: CLINICAL, PATIENT REPORTED AND HEALTH ECONOMIC OUTCOMES. |
Epidemiology and Public Health Research |
Abstract |
| 094 |
Camila A Picchio |
LATE PRESENTATION OF CHRONIC HEPATITIS B AND C VIRUS IN PEOPLE WHO INJECT DRUGS IN SPAIN DESPITE UNRESTRICTED ACCESS TO HBV AND HCV THERAPY |
Epidemiology and Public Health Research |
Abstract |
| 095 |
Alisa Pedrana |
THE IMPACT OF COMMUNITY-BASED RAPID POINT-OF-CARE TESTING ON ENHANCING UPTAKE OF HEPATITIS C TREATMENT FOR PEOPLE WHO INJECT DRUGS IN NEEDLE AND SYRINGE SERVICES. |
Epidemiology and Public Health Research |
Abstract |
| 096 |
Alisa Pedrana |
A GLOBAL INVESTMENT FRAMEWORK FOR HEPATITIS C ELIMINATION |
Epidemiology and Public Health Research |
Abstract |
| 097 |
Alisa Pedrana |
HEPATITIS C ANTIBODY TESTING TREND PRE AND POST UNIVERSAL ACCESS TO DIRECT ACTING ANTIVIRALS IN AUSTRALIA: SEGMENTED REGRESSION OF PRIMARY CARE CLINIC DATA. |
Epidemiology and Public Health Research |
Abstract |
| 098 |
Christian Ramers |
DRUG USE HABITS, OVERDOSE EXPERIENCE, AND INFECTIOUS DISEASE RISK BEHAVIORS AMONG PARTICIPANTS IN AN URBAN SYRINGE EXCHANGE PROGRAM |
Epidemiology and Public Health Research |
Abstract |
| 099 |
Phillip Read |
WHEN TREATMENT ACCESS DOES NOT EQUAL TREATMENT INITIATION: AN ANALYSIS OF CLIENTS WHO DO NOT INITIATE DIRECT ACTING ANTIVIRALS |
Epidemiology and Public Health Research |
Abstract |
| 100 |
Eli Rosenberg |
A STANDARDIZATION MODEL FOR ESTIMATING POPULATIONS OF PERSONS WHO INJECT DRUGS IN US STATES, 2017 |
Epidemiology and Public Health Research |
Abstract |
| 101 |
Andrew Scheibe |
HEPATITIS C AND HIV CO-INFECTION AMONG PEOPLE WHO USE DRUGS AND OTHER KEY POPULATIONS IN SOUTH AFRICA: FINDINGS FROM A SEVEN-CITY CROSS-SECTIONAL SURVEY |
Epidemiology and Public Health Research |
Abstract |
| 102 |
Nick Scott |
UPSCALING PREVENTION, TESTING AND TREATMENT TO CONTROL HEPATITIS C AS A PUBLIC HEALTH THREAT IN DAR ES SALAAM, TANZANIA |
Epidemiology and Public Health Research |
Abstract |
| 103 |
Nick Scott |
A GLOBAL INVESTMENT CASE FOR HEPATITIS C |
Epidemiology and Public Health Research |
Abstract |
| 104 |
Sanjeev Sirpal |
BARRIERS TO HEPATITIS C DIAGNOSIS AND TREATMENT IN THE DAA ERA: REVIEW OF THE LITERATURE AND RESULTS OF A COMMUNITY-BASED SURVEY OF PRIMARY CARE PRACTITIONERS |
Epidemiology and Public Health Research |
Abstract |
| 105 |
Kathryn Snow |
SUBSTANCE USE, MENTAL HEALTH, AND HEALTHCARE COSTS AFTER RELEASE FROM AUSTRALIAN PRISONS |
Epidemiology and Public Health Research |
Abstract |
| 106 |
Kwame Thompson |
SPONTANEOUS REMISSION IN HCV-EXPOSED AFRICAN-AMERICAN AND HISPANIC IV DRUG USERS TESTED IN 2018-2019 |
Epidemiology and Public Health Research |
Abstract |
| 107 |
Kirsten Trayner |
RAISED RISK OF BLOOD BORNE VIRUS INFECTION AND OTHER DRUG RELATED HARMS AMONG PEOPLE WHO INJECT DRUGS IN PUBLIC PLACES |
Epidemiology and Public Health Research |
Abstract |
| 108 |
Jorge Valencia |
HCV INFECTION RISK AND GENDER VULNERABILITY OF WOMEN WHO INJECT DRUGS. |
Epidemiology and Public Health Research |
Abstract |
| 109 |
Cristina Valente |
CURRENT PRACTICES OF SCREENING HEPATITIS C INFECTION IN AN INTEGRATED RESPONSE CENTER FOR ADDITIVE AND DEPENDENCE BEHAVIOURS |
Epidemiology and Public Health Research |
Abstract |
| 110 |
Aaron Vanderhoff |
ASSESSMENT OF HEPATITIS C SCREENING STRATEGIES IN DIFFERENT COMMUNITY SETTINGS IN A CANADIAN METROPOLITAN AREA |
Epidemiology and Public Health Research |
Abstract |
| 111 |
Paul Haber |
OVERCOMING INSTITUTIONAL BARRIERS TO INTEGRATED CARE: LINKAGE TO HEPATITIS C TREATMENT IN THE OPIOID AGONIST TREATMENT SETTING |
Social Science and Policy Research |
Abstract |
| 112 |
Darcy Bowman |
BEYOND CLINICAL OUTCOMES: IMPACT AND WIDER SOCIAL AND HEALTHCARE SYSTEM IMPLICATIONS OF HEPATITIS C VIRUS (HCV) TREATMENT AND CURE |
Social Science and Policy Research |
Abstract |
| 113 |
Susan Chong |
HEPATITIS C TREATMENT: PEER INSIGHTS TO UNDERSTANDING ENABLERS AND IMPEDIMENTS TO DAA UPTAKE AMONG PEOPLE WHO INJECT DRUGS |
Social Science and Policy Research |
Abstract |
| 114 |
Tianna Magel |
LOW LEVELS OF HCV KNOWLEDGE IN KEY POPULATIONS: A BARRIER TO HCV ELIMINATION188 |
Social Science and Policy Research |
Abstract |
| 115 |
Alberto Moriggia |
EDUCATION ON ADDICTION MEDICINE IN THE BASIC HEALTH CARE TRAINING: THE EXPERIENCE OF SWITZERLAND |
Social Science and Policy Research |
Abstract |
| 116 |
Marie Jauffret-Roustide |
HCV CRISIS AMONG RUSSIAN-SPEAKING INJECTING DRUG USERS IN FRANCE: THE URGENT NEED TO IMPROVE ACCESS TO CARE AND SOCIAL INTEGRATION |
Social Science and Policy Research |
Abstract |
| 117 |
George Kalamitsis |
FACTORS ASSOCIATED WITH LOW RATES OF ENGAGEMENT IN OPIOID SUBSTITUTION TREATMENT AMONG PEOPLE WHO USE DRUGS IN ATHENS |
Social Science and Policy Research |
Abstract |
| 118 |
Naren Nallapeta |
HCV MICROELIMINATION - IMPLEMENTATION OF THE INTERNIST-ADDICTION MEDICINE-HEPATOLOGY COLOCALIAZATION (IAHC) MODEL |
Social Science and Policy Research |
Abstract |
| 119 |
Elana Rosenthal |
IF WE BUILD IT, WILL THEY COME? HIGH INTEREST IN SIF AMONG PWID WITH HCV IN WASHINGTON, DC |
Social Science and Policy Research |
Abstract |
| 120 |
Adam Palayew |
THE IMPLEMENTATION OF HARM REDUCTION AND HEPATITIS C SERVICES FOR PEOPLE WHO INJECT DRUGS IN EUROPE: RESULTS FROM THE 2018 HEP-CORE SURVEY |
Social Science and Policy Research |
Abstract |
| 121 |
Bruce Schackman |
COST OF HEPATITIS C CARE FACILITATION FOR HIV/HEPATITIS C CO-INFECTED PEOPLE WHO USE SUBSTANCES |
Social Science and Policy Research |
Abstract |
| 122 |
Bernice Thompson |
STAMSH SLHANAY LLHWAT – WARRIOR WOMEN HEALING |
Social Science and Policy Research |
Abstract |
| 123 |
Zoe Ward |
A COST-EFFECTIVENESS ANALYSIS OF AN INTERVENTION TO INCREASE LINKAGE TO CARE OF HCV-INFECTED PATIENTS ON OPIOID SUBSTITUTION THERAPY (HEPLINK IRELAND) |
Epidemiology and Public Health Research |
Abstract |
| 124 |
Jack Williams |
A THRESHOLD ANALYSIS OF THE COST-EFFECTIVENESS OF HEPATITIS C TESTING IN EMERGENCY DEPARTMENTS IN THE U |
Epidemiology and Public Health Research |
Abstract |
| 125 |
Hannah Zellman |
HEPATITIS C PREVALENCE AND RISK FACTORS AMONG PEOPLE WHO ENGAGE IN TRANSACTIONAL SEX WORK, PHILADELPHIA. |
Epidemiology and Public Health Research |
Abstract |
| 126 |
Hannah Zellman |
HEALTH CARE ACCESS AMONG DRUG USERS IN PHILADELPHIA |
Epidemiology and Public Health Research |
Abstract |
| 127 |
Mark Cassell |
IMPROVED LINKAGE TO HEPATITIS C ASSESSMENT AND TREATMENT WITHIN COMMUNITY DRUG SERVICES THROUGH COMBINED HEPATITIS C AND OPIATE SUBSTITUTION TREATMENT PRESCRIPTION APPOINTMENTS |
Models of Care |
Abstract |
| 128 |
Sarah Donaldson |
“ASK A FRIEND” IDENTIFYING THE HIDDEN POPULATION: FORMER INTRAVENOUS DRUG USERS WHO ARE NO LONGER IN CONTACT WITH SERVICES. A RESPONDENT DRIVEN SAMPLING PROTOCOL. |
Models of Care |
Abstract |
| 129 |
Monty Ghosh |
SEAMLESS INTEGRATION OF HEPATITIS C TREATMENT WITHIN AN INTRAVENOUS (IV) HYDROMORPHONE OPIOID AGONIST TREATMENT (IOAT) PROGRAM. |
Models of Care |
Abstract |
| 130 |
Pamela Lynch |
RURAL US DRUG USER HEALTH THROUGH SYRINGE ACCESS PROGRAMMING |
Models of Care |
Abstract |
| 131 |
Megan Stephen |
COLLABORATIVE WORKING WITH COMMUNITY PHARMACIES INCREASES TESTING AND ENHANCES ACCESS TO DIRECT ACTING ANTIVIRAL (DAA) THERAPY FOR HEPATITIS C (HCV) |
Models of Care |
Abstract |
| 132 |
Phillip Read |
IMPROVING SVR12 FOLLOW-UP IN PRIMARY CARE WITH A STRUCTURED HEPATITIS C ASSESSMENT TOOL |
Models of Care |
Abstract |
| 133 |
Sara Alsterberg |
HEPATITIS C TREATMENT AT A SWEDISH NEEDLE EXCHANGE PROGRAM: A SUCCESSFUL FULL-SERVICE MODEL FOR REACHING ACTIVE INJECTORS |
Models of Care |
Abstract |
| 134 |
Andreea Adelina Artenie |
THE ST LUC COHORT: A LONGITUDINAL STUDY SERVING AS A STEPPING STONE TO HCV TREATMENT INITIATION AMONG PEOPLE WHO INJECT DRUGS |
Models of Care |
Abstract |
| 135 |
Amélie Bédard |
IMPLEMENTATION OF A MODEL OF CARE FOR THE SCREENING AND TREATMENT OF HEPATITIS C IN THE OBEDJIWAN INDIGENOUS COMMUNITY WITH THE GOAL OF ELIMINATION |
Models of Care |
Abstract |
| 136 |
Angelica Bedrosian |
HEPATITIS C CARE, OPIOID USE DISORDER TREATMENT, AND SYRINGE SERVICE PROGRAMMING: AN INTEGRATED APPROACH |
Models of Care |
Abstract |
| 137 |
Lynne Biggart |
USING POINT OF CARE TESTING, SIMPLIFIED ASSESSMENT AND MONITORING AND NURSE/PHARMACIST/ADDICTIONS OFFICER INITIATION OF TREATMENT: RESULTS FROM PHASE 1 OF THE SPRINGBURN MICROELIMINATION PROJECT. |
Models of Care |
Abstract |
| 138 |
Hugo Bissonnet |
INTEGRATED APPROACH TO COMMUNITY-BASED DRUG TESTING (IACBDT) IN THE LAURENTIANS IN QUEBEC TO PREVENT DEATHS FROM OPIOID OVERDOSES |
Models of Care |
Abstract |
| 139 |
Matthew Bonn |
PALS: LENDING A HAND TO PEOPLE WHO USE SUBSTANCES TRANSITIONING OUT OF CENTRAL NOVA SCOTIA (CANADA) CORRECTIONAL FACILITY |
Models of Care |
Abstract |
| 140 |
Matthew Bonn |
HEPNS: CURBING HEPATITIS C TRANSMISSION THROUGH EFFECTIVE LINKAGE OF PEOPLE WHO INJECT SUBSTANCES TO TREATMENT IN NOVA SCOTIA, CANADA |
Models of Care |
Abstract |
| 141 |
Stefan Bourgeois |
LINKAGE TO CARE: ADDED VALUE OF C-BUDDIES IN THE TREATMENT OF HEPATITIS C IN PERSONS WHO USE OR INJECT DRUGS |
Models of Care |
Abstract |
| 142 |
Lauren Bradley |
IMPLEMENTING BEST PRACTICE MODELS OF CARE IN CUSTODIAL SETTINGS IN AUSTRALIA: WHAT ROLE DOES THE NATIONAL HEPATITIS C STRATEGY PLAY? |
Models of Care |
Abstract |
| 143 |
Taha Brahni |
ISSUES OF ADHERENCE TO THE OPIOID SUBSTITUTION THERAPY IN THE NORTH OF MOROCCO |
Models of Care |
Abstract |
| 144 |
Dana Busschots |
REACHING OUT TO THE UNDIAGNOSED PEOPLE WITH HEPATITIS C INFECTION IN BELGIUM |
Models of Care |
Abstract |
| 145 |
Christopher Byrne |
TREATMENT OF HCV/HIV CO-INFECTION IN NHS TAYSIDE, SCOTLAND, 2001-2019 |
Models of Care |
Abstract |
| 146 |
Hugo Armando Castro Cortes |
COMMUNITY-BASED APPROACH TO HEPATITIS C IN PEOPLE WHO INJECT DRUGS, IN PEREIRA, COLOMBIA. |
Models of Care |
Abstract |
| 147 |
Chris Cavacuiti |
A CLOUD-BASED APPROACH TO HEPATITIS C CARE IN PATIENTS WITH SUBSTANCE USE |
Models of Care |
Abstract |
| 148 |
Elizabeth Crock |
SCALING-UP FOR HEPATITIS C ELIMINATION – LESSONS FROM A SUCCESSFUL PARTNERSHIP BETWEEN AN HIV AND HOMELESSNESS NURSING PROGRAM AND AN HIV/AIDS SERVICE ORGANIZATION IN MELBOURNE, AUSTRALIA. |
Models of Care |
Abstract |
| 149 |
Jina Devi |
LINKAGE TO HCV CARE AND TREATMENT AMONG PEOPLE WHO USE OR INJECT DRUG |
Models of Care |
Abstract |
| 150 |
Joseph Doyle |
A NURSE-LED, COMMUNITY BASED MODEL OF HEPATITIS C CARE IN MELBOURNE, AUSTRALIA; 2017-2018 |
Models of Care |
Abstract |
| 151 |
Sandra Dröse |
A MODEL OF CARE FOR PEOPLE ATTENDING DRUG TREATMENT CENTERS AIMING AT HEPATITIS C ELIMINATION BY 2022. A PART OF THE C- FREE SOUTH STRATEGY |
Models of Care |
Abstract |
| 152 |
Colleen Flanigan |
AN INITIATIVE AIMED AT BUILDING CAPACITY IN HEALTHCARE ORGANIZATIONS TO PROVIDE STIGMA-FREE CARE TO PEOPLE WHO USE DRUGS. |
Models of Care |
Abstract |
| 153 |
Marie-ève Goyer |
INTEGRATED AND LOW-THRESHOLD MODELS OF CARE IN OPIOID AGONIST TREATMENT CENTERS: ARE WE THERE YET IN QUÉBEC? |
Models of Care |
Abstract |
| 154 |
Louise Hansford |
ACCESSING THE INACCESIBLE: AN INNOVATIVE APPROACH TO HEPATITIS C TESTING AND TREATMENT IN THE COMMUNITY |
Models of Care |
Abstract |
| 155 |
Mamta Jain |
HEPATITIS C TREATMENT IN HIV PATIENTS: COMPARISON BETWEEN TREATMENT LIVER SPECIALTY VS. PRIMARY CARE |
Models of Care |
Abstract |
| 156 |
Shashi Kapadia |
THE ROLE OF A HEPATITIS C CARE COORDINATOR IN PROVIDING COMPREHENSIVE CARE TO FACILITATE HEPATITIS C TREATMENT AMONG PEOPLE WHO INJECT DRUGS |
Models of Care |
Abstract |
| 157 |
Dominique Larrey |
EFFICACY OF HCV INFECTION TREATMENT USING A “GO-TO-THE-PATIENT” ACTION AMONG PATIENTS NOT ATTENDING STANDARD MEDICAL CARE CENTRES WITH ACTIVE/ SUBSTITUED DRUG/ALCOHOL ADDICTION AND/OR HIGH SOCIAL PRECARIOUSNESS |
Models of Care |
Abstract |
| 158 |
Yin Liu |
THE OPTIMAL STRATEGY OF HEPATITIS C THERAPY IN GENOTYPE 1B TREATMENT-NAÏVE PATIENTS WHO INJECT DRUGS IN CHINA: A DECISION AND COST-EFFECTIVENESS ANALYSIS |
Models of Care |
Abstract |
| 159 |
Saveria Lory, Crocè |
“FIVE STEPS” INTO THE TRIESTE INTEGRATE MODEL FOR TREATMENT OF HEPATITIS C IN PEOPLE WHO INJECT DRUGS. |
Models of Care |
Abstract |
| 160 |
Stéphanie Marsan |
USING THE PROJECT ECHO MODEL OF CARE TO INCREASE ACCESS TO ADDICTION MEDICINE SERVICES FOR FIRST NATIONS AND INUIT COMMUNITIES IN THE PROVINCE OF QUEBEC |
Models of Care |
Abstract |
| 161 |
Cristiana Merendeiro |
HIV AND HCV SCREENINGS IN HARM REDUCTION SETTINGS - A PILOT PROJECT BASED ON A PROXIMITY STRATEGY |
Models of Care |
Abstract |
| 162 |
Håvard Midgard |
THE HEPATITIS C CASCADE OF CARE AND TREATMENT OUTCOMES AMONG PEOPLE WHO INJECT DRUGS IN A NORWEGIAN LOW-THRESHOLD SETTING: A REAL LIFE EXPERIENCE |
Models of Care |
Abstract |
| 163 |
Eithne Nic an Riogh |
THE HEPCARE MODEL OF INTEGRATED CARE IMPROVES CLINIC ATTENDANCE IN ‘HARD TO REACH’ HEPATITIS C POSITIVE PATIENTS |
Models of Care |
Abstract |
| 164 |
Margaret O'sullivan |
PROJECT ITTREAT (INTEGRATED COMMUNITY BASED TEST – STAGE-TREAT HCV SERVICE) FOR PEOPLE WHO INJECT DRUGS: CLINICAL, PATIENT REPORTED AND HEALTH ECONOMIC OUTCOMES. |
Models of Care |
Abstract |
| 165 |
Alisa Pedrana |
SUPPORTING PRIMARY CARE CLINICS TO PRIORITISE HEPATITIS C TESTING AND TREATMENT THROUGH THE PROVISION OF A TAILORED PACKAGE OF INTERVENTIONS – THE EC NURSE-LED MODEL |
Models of Care |
Abstract |
| 166 |
Cláudia Pereira |
A PROXIMITY HARM REDUCTION APPROACH TO IMPROVE HCV TREATMENT ADHERENCE |
Models of Care |
Abstract |
| 167 |
Chase Perfect |
ADDRESSING INSUFFICIENT HCV KNOWLEDGE AND SERVICE CAPACITY THROUGH COMMUNITY-LED TRAININGS ON HCV AND MARGINALIZED POPULATIONS’ NEEDS |
Models of Care |
Abstract |
| 168 |
Phillip Olesen |
APPLYING BEHAVIOURAL INTERVENTIONS TO INCREASE HCV SCREENING RATES IN COMMUNITY DRUG TREATMENT SETTINGS |
|
Abstract |
| 169 |
Phillip Read |
ACCESSING HIDDEN POPULATIONS: AN EXTENDED OUTREACH SERVICE OF THE KIRKETON ROAD CENTRE |
Models of Care |
Abstract |
| 170 |
Sarah Rowan |
VIRAL HEPATITIS TESTING AND LINKAGE TO CARE FOR INDIVIDUALS ENROLLED IN OPIOID TREATMENT PROGRAMS IN DENVER, COLORADO |
Models of Care |
Abstract |
| 171 |
Andrew Scheibe |
VIRAL HEPATITIS C PREVALENCE, INCIDENCE, INJECTING PRACTICES AND LINKAGE TO CARE AMONG PEOPLE WHO INJECT DRUGS PARTICIPATING IN A METHADONE MAINTENANCE THERAPY PILOT PROJECT IN CAPE TOWN, SOUTH AFRICA. |
Models of Care |
Abstract |
| 172 |
Kathleen Seneca |
NALTREXONE XR (XR-NTX) CAN BE USED TO SUPPORT HEPATITIS C VIRUS (HCV) TREATMENT IN YOUNG MEDICALLY WITHDRAWN PERSONS WHO INJECT DRUGS (PWIDS) – A PRELIMINARY REPORT |
Models of Care |
Abstract |
| 173 |
Christian Sharkey |
IMAGE AND PERFORMANCE ENHANCING DRUGS, A RISK FOR HCV OR FATTY LIVER DISEASE? |
Models of Care |
Abstract |
| 174 |
David Wicks |
ONSITE CASE MANAGEMENT- BRIDGING THE DIVIDE BETWEEN HCV DIAGNOSIS AND TREATMENT FOR PEOPLE WHO INJECT DRUGS. |
Models of Care |
Abstract |
| 175 |
Marie Sutton |
A PERFECT STORM AND A PERFECT OPPORTUNITY: THE STORY OF AN INNOVATIVE HCV SCREENING AND LTC PROGRAM FOR SUBSTANCE USERS IN GEORGIA |
Models of Care |
Abstract |
| 176 |
Jan Tait |
ACHIEVING HEPATITIS C ELIMINATION: A CHANGE IN A CARE PATHWAY WITHIN A PRISON INCREASES ACCESS TO HEPATITIS C TREATMENT. |
Models of Care |
Abstract |
| 177 |
Effrosyni Tsirogianni |
MICRO-ELIMINATION OF HEPATITIS C AMONG INCARCERATED POPULATION: THE INTERVENTION ACCESS4ALL IN A LARGE PRISON OF THESSALONIKI, GREECE |
Models of Care |
Abstract |
| 178 |
Megan Urry |
LOW THRESHOLD SERVICES FOR PWUD: INTEGRATING BUPRENORPHINE INTO A COMPREHENSIVE HIV, HCV AND SEXUAL HEALTH CARE AND TREATMENT PROGRAM IN NEW YORK CITY |
Models of Care |
Abstract |
| 179 |
Claire Wartelle-bladou |
FIRST FRENCH-SPEAKING ECHO® HEPATITIS C TELEMENTORING PROGRAM: EVALUATION AT YEAR-TWO. |
Models of Care |
Abstract |
| 180 |
Bradley Whitton |
INTEGRATING HEPATITIS C CARE WITH MENTAL HEALTH AND ALCOHOL AND OTHER DRUG SERVICES |
Models of Care |
Abstract |
| 181 |
Cara Skillingstead |
EDUCATION TO REDUCE HIV/HBV/HCV TRANSMISSION IN INCARCERATED POPULATIONS |
Models of Care |
Abstract |
| 182 |
Daniel Winetsky |
CHANGES IN HOUSING STABILITY AND TREATMENT FOR OPIOID USE DISORDER DURING HEPATITIS C TREATMENT AT A HARM REDUCTION PROGRAM |
Models of Care |
Abstract |
| 183 |
Daniel Winetsky |
THE IMPACT OF PSYCHOSOCIAL FACTORS ON THE CARE CASCADE FOR HEPATITIS C TREATMENT AT A HARM REDUCTION PROGRAM |
Models of Care |
Abstract |
| 184 |
Debbie Winwood |
MAPPING HEPATITIS C SERVICES TO REMOVE BARRIERS TO TREATMENT FOR PEOPLE WHO INJECT DRUGS |
Models of Care |
Abstract |
| 185 |
Debbie Winwood |
WWW.WORKING WITHIN WALSALL TO ELIMINATE HEPATITIS C: FROM TEST TO CURE |
Models of Care |
Abstract |
| 186 |
Alexander Wong |
AN ON-SITE NURSE-LED PROTOCOL-DRIVEN MODEL OF CARE IMPROVES ACCESS TO HCV TREATMENT FOR TRANSIENTLY INCARCERATED PERSONS IN A PROVINCIAL CORRECTIONAL FACILITY IN SASKATCHEWAN, CANADA |
Models of Care |
Abstract |
| 187 |
Klaudia Zabrzenski |
THE ACE TEAM- AN INNER CITY OUTREACH TEAM FOR HIGH BARRIER HIV AND HEPATITIS C INDIVIDUALS |
Models of Care |
Abstract |
| 188 |
Nicolas Clark |
TREATMENT OF HEPATITIS C IN A MEDICALLY SUPERVISED INJECTING ROOM: A MODEL FOCUSED ON REDUCING BARRIERS TO INITIATION |
|
|
| 189 |
Jasna Cernosa |
STAGE OF LIVER FIBROSIS IN PEOPLE WHO INJECT DRUGS MANAGED AT LOW-THRESHOLD SETTINGS IN SLOVENIA: RESULTS OF A NATIONAL STUDY |
|
|
| 190 |
Pascal Melin |
FEATURING SCREENING HEPATITIS C AND SOCIAL NETWORK MANY EX DRUG USERS AMONG ALCOOLIC POPULATION: SCREENING HEPATITIS C ON A FACEBOOK GROUP CALLED “MOIS SOBRE” |
|
Abstract |
| 191 |
Mim O'Flynn |
WHAT DOES HCV CARE LOOK LIKE TO YOU? |
|
|
